Table 6 Comparison of patients with the lowest and highest baseline triglyceride levels at baseline
From: Impact of lipodystrophy on health-related quality of life: the QuaLip study
|  | Lowest triglyceride tertile (n = 22) | Highest triglyceride tertile (n = 22) | p value |
|---|---|---|---|
Age | 39 (29–52) | 35 (26–44) | 0.250 |
Height (cm) | 165 (162–173) | 160 (155–165) | 0.109 |
Weight (kg) | 67 (57–75) | 53 (50–62) | 0.009 |
BMI (kg/m2) | 24.20 (20.76–28.24) | 20.70 (18.37–25.08) | 0.033 |
HbA1c (%) | 6.0 (5.6–8.0) | 7.3 (6.4–9.3) | 0.015 |
FBG (mg/dL) | 95.50 (89.00–145.00) | 150.00 (111.00–190.00) | 0.022 |
Triglyceride (mg/dL) | 128.50 (100.00–144.00) | 608.50 (485.00–888.00) |  < 0.001 |
LDL (mg/dL) | 123.50 (95.00–137.00) | 113.50 (91.00–125.00) | 0.359 |
HDL (mg/dL) | 43.50 (35.00–51.00) | 29.50 (25.00–33.50) | 0.001 |
Leptin (ng/mL) | 7.06 (2.91–12.77) | 0.97 (0.38–4.19) | 0.015 |
ALT (U/L) | 23.50 (18–28.50.00) | 23.00 (15.00–29.00) | 0.876 |
WBC (103/μL) | 7.50 (6.70–8.90) | 7.40 (6.80–8.60) | 0.900 |
Hemoglobin (g/dL) | 13.00 (12.70–13.80) | 12.40 (11.60–13.40) | 0.249 |
Hematocrit (%) | 40.00 (37.80–40.70) | 36.60 (34.80–39.50) | 0.079 |
Platelet (103/μL) | 257.50 (180.50–327.50) | 281.00 (221.00–356.00) | 0.214 |
SF36_PF | 80.00 (45.00–90.00) | 60.00 (45.00–85.00) | 0.532 |
SF36_RP | 75.00 (25.00–100.00) | 0.00 (0.00–100.00) | 0.036 |
SF36_RE | 66.67 (33.33–100.00) | 0.17 (0.00–66.67) | 0.056 |
SF36_VT | 55.00 (50.00–75.00) | 40.00 (20.00–65.00) | 0.073 |
SF36_MH | 62.00 (52.00–76.00) | 52.00 (40.00–64.00) | 0.157 |
SF36_SF | 75.00 (62.50–100.00) | 62.50 (37.50–75.00) | 0.058 |
SF36_BP | 78.75 (45.00–100.00) | 50.00 (32.50–90.00) | 0.071 |
SF36_GH | 45.00 (30.00–60.00) | 30.00 (30.00–45.00) | 0.121 |
Beck depression score | 12.50 (5.00–22.00) | 18.00 (7.00–25.00) | 0.176 |
EQ-5D-5L index value | 0.71 (0.64–0.88) | 0.50 (0.16–0.76) | 0.041 |
EQ-5D-5L VAS | 80.00 (75.00–90.00) | 67.50 (50.00–80.00) | 0.052 |
Facit fatigue score | 32.50 (24.00–42.00) | 23.00 (15.00–35.00) | 0.069 |